FERRING PHARMACEUTICALS INC.
Lobbying client. Federal LDA filings.
Connected on the graph
Inbound (19)
| date | from | type | amount | role | source |
|---|---|---|---|---|---|
| — | Deema Tarazi | lobbied_for | — | lda_lobbyist_client | |
| — | David Reid | lobbied_for | — | lda_lobbyist_client | |
| — | Brandt Anderson | lobbied_for | — | lda_lobbyist_client | |
| — | Harold Hancock | lobbied_for | — | lda_lobbyist_client | |
| — | Tim Shadyac | lobbied_for | — | lda_lobbyist_client | |
| — | Brian Ballard | lobbied_for | — | lda_lobbyist_client | |
| — | Adam Steinmetz | lobbied_for | — | lda_lobbyist_client | |
| — | Edward Randall Royce | lobbied_for | — | lda_lobbyist_client | |
| — | Hunter Morgen | lobbied_for | — | lda_lobbyist_client | |
| — | Joseph Brady Howell | lobbied_for | — | lda_lobbyist_client | |
| — | Mark L. Pryor | lobbied_for | — | lda_lobbyist_client | |
| — | Emily Felder | lobbied_for | — | lda_lobbyist_client | |
| — | Tegan Gelfand | lobbied_for | — | lda_lobbyist_client | |
| — | Aaron Cummings | lobbied_for | — | lda_lobbyist_client | |
| — | Jonathan Towers | lobbied_for | — | lda_lobbyist_client | |
| — | Alison Anway | lobbied_for | — | lda_lobbyist_client | |
| 2026-01-01 | BALLARD PARTNERS, LLC | lobbies_for | $110,000 | lda_filing | |
| 2026-01-01 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | lobbies_for | $50,000 | lda_filing | |
| 2026-01-01 | FERRING PHARMACEUTICALS, INC. | lobbies_for | $220,000 | lda_filing |
Outbound (8)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | lobbies_on_bill | HR 1670 — Family Building FEHB Fairness Act | — | H.R. 1670 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 1878 — IVF Access and Affordability Act | — | H.R. 1878 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 220 — Veterans Infertility Treatment Act of 2025 | — | H.R. 220 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 4299 — Protecting Patient Access to Cancer and Complex Therapies Act | — | H.R. 4299 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 4639 — Infertility Treatment Affordability Act of 2025 | — | H.R. 4639 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 6797 — Bipartisan IVF for Military Families Act | — | H.R. 6797 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 8119 — HOPE with Fertility Services Act | — | H.R. 8119 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 797 — Family Building FEHB Fairness Act | — | S. 797 | lobbying_bill_mention |
- Source id
55802- General description
- biopharmaceutical company
- State
- NJ
- Country
- US
- Principal place of business
- US
- Effective date
- 2023-04-01
- Total spend (across 1 ingested filings)
- $50,000
Filings
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-18 | Q1 | 2026 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $50,000 |